Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.
View Top Employees from Knight TherapeuticsLooking for a particular Knight Therapeutics employee's phone or email?
Knight Therapeutics Questions
The Knight Therapeutics annual revenue was $6 million in 2024.
Amal Khouri is the Chief Business Officer of Knight Therapeutics.
284 people are employed at Knight Therapeutics.
Knight Therapeutics is based in Montreal, Quebec.
The NAICS codes for Knight Therapeutics are [3254, 32541, 32, 325].
The SIC codes for Knight Therapeutics are [28, 283].
Top Knight Therapeutics Employees
-
11
-
21
-
2
-
35
-
31
-
View
Mauricio Arantes Figueiredo
Associate Director Business Development at Knight Therapeutics
Sao Paulo, Sao Paulo, Brazil55+ -
View
Stephani Saverio
VP of Business Development and Head of Global BD at Knight Therapeutics
São Paulo, SP, BR35+
Related Companies
